At the molecular level, the development of atherosclerosis is driven by the dysregulation of lipid metabolic proteins, including PCSK9, LOX-1, CD36, and ABCA1, which are key proteins that contribute to the atherosclerosis process and have important roles in lipid metabolism and the formation of atherosclerotic plaques. Here, ABCA1 is linked to atherosclerosis.